Innovation in Pediatric Drugs Act of 2024

[AI summary unavailable — showing source text] [Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [S. 4905 Introduced in Senate (IS)] <DOC> 118th CONGRESS 2d Session S. 4905 To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES July 31, 2024 Mr. Reed (for himself and Mrs. Capito) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions _______________________________________________________________________ A BILL To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Innovation in Pediatric Drugs Act of 2024''. SEC. 2. ENSURING COMPLETION OF PEDIATRIC STUDY REQUIREMENTS. (a) Equal Accountability for Pediatric Study Requirements.--Section 505B(d) of the Federal Food, Drug, and Cosme…